US cannabis companies anticipate greater access to IPOs and private funding as federal cannabis restrictions ease. Executives believe reduced stigma and relaxed banking rules will attract mainstream investors, despite ongoing regulatory complexities between state and federal laws.

Executives say stigma reduction and eased banking rules may attract mainstream investors; rescheduling may open Initial Public Offering (IPO) opportunities on major U.S. exchanges; companies still face regulatory uncertainty due to differing state and federal cannabis policies